private:lambdavision-2
|
6930248
|
May 29th, 2019 12:00AM
|
LambdaVision, Inc.
|
118
|
7.00
|
Open
|
Biotechnology
|
May 29th, 2019 10:34AM
|
May 29th, 2019 10:34AM
|
LambdaVision, Inc. seeks to harness the photochemical properties of retinylidene proteins to develop a high-resolution, protein-based retinal prosthesis for the restoration of vision and improvement of the quality of life for those patients afflicted by retinal degenerative diseases.
|
Open
|
|
Open
|
400 Farmington Ave
|
Farmington
|
Connecticut
|
US
|
06032
|
|
LambdaVision
|
|
Pharmaceuticals & Biotechnology
|
private:lambdavision-2
|
6930248
|
Feb 17th, 2018 12:00AM
|
LambdaVision, Inc.
|
46
|
6.00
|
Open
|
Biotechnology
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
LambdaVision, Inc. seeks to harness the photochemical properties of retinylidene proteins to develop a high-resolution, protein-based retinal prosthesis for the restoration of vision and improvement of the quality of life for those patients afflicted by retinal degenerative diseases.
|
|
|
|
|
|
|
|
|
|
LambdaVision
|
|
Pharmaceuticals & Biotechnology
|
private:lambdavision-2
|
6930248
|
Feb 16th, 2018 12:00AM
|
LambdaVision, Inc.
|
46
|
6.00
|
Open
|
Biotechnology
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
LambdaVision, Inc. seeks to harness the photochemical properties of retinylidene proteins to develop a high-resolution, protein-based retinal prosthesis for the restoration of vision and improvement of the quality of life for those patients afflicted by retinal degenerative diseases.
|
|
|
|
|
|
|
|
|
|
LambdaVision
|
|
Pharmaceuticals & Biotechnology
|
private:lambdavision-2
|
6930248
|
Feb 15th, 2018 12:00AM
|
LambdaVision, Inc.
|
46
|
6.00
|
Open
|
Biotechnology
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
LambdaVision, Inc. seeks to harness the photochemical properties of retinylidene proteins to develop a high-resolution, protein-based retinal prosthesis for the restoration of vision and improvement of the quality of life for those patients afflicted by retinal degenerative diseases.
|
|
|
|
|
|
|
|
|
|
LambdaVision
|
|
Pharmaceuticals & Biotechnology
|
private:lambdavision-2
|
6930248
|
Feb 14th, 2018 12:00AM
|
LambdaVision, Inc.
|
46
|
6.00
|
Open
|
Biotechnology
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
LambdaVision, Inc. seeks to harness the photochemical properties of retinylidene proteins to develop a high-resolution, protein-based retinal prosthesis for the restoration of vision and improvement of the quality of life for those patients afflicted by retinal degenerative diseases.
|
|
|
|
|
|
|
|
|
|
LambdaVision
|
|
Pharmaceuticals & Biotechnology
|
private:lambdavision-2
|
6930248
|
Feb 13th, 2018 12:00AM
|
LambdaVision, Inc.
|
46
|
6.00
|
Open
|
Biotechnology
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
LambdaVision, Inc. seeks to harness the photochemical properties of retinylidene proteins to develop a high-resolution, protein-based retinal prosthesis for the restoration of vision and improvement of the quality of life for those patients afflicted by retinal degenerative diseases.
|
|
|
|
|
|
|
|
|
|
LambdaVision
|
|
Pharmaceuticals & Biotechnology
|
private:lambdavision-2
|
6930248
|
Feb 12th, 2018 12:00AM
|
LambdaVision, Inc.
|
46
|
6.00
|
Open
|
Biotechnology
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
LambdaVision, Inc. seeks to harness the photochemical properties of retinylidene proteins to develop a high-resolution, protein-based retinal prosthesis for the restoration of vision and improvement of the quality of life for those patients afflicted by retinal degenerative diseases.
|
|
|
|
|
|
|
|
|
|
LambdaVision
|
|
Pharmaceuticals & Biotechnology
|
private:lambdavision-2
|
6930248
|
Feb 11th, 2018 12:00AM
|
LambdaVision, Inc.
|
46
|
6.00
|
Open
|
Biotechnology
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
LambdaVision, Inc. seeks to harness the photochemical properties of retinylidene proteins to develop a high-resolution, protein-based retinal prosthesis for the restoration of vision and improvement of the quality of life for those patients afflicted by retinal degenerative diseases.
|
|
|
|
|
|
|
|
|
|
LambdaVision
|
|
Pharmaceuticals & Biotechnology
|
private:lambdavision-2
|
6930248
|
Feb 10th, 2018 12:00AM
|
LambdaVision, Inc.
|
46
|
6.00
|
Open
|
Biotechnology
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
LambdaVision, Inc. seeks to harness the photochemical properties of retinylidene proteins to develop a high-resolution, protein-based retinal prosthesis for the restoration of vision and improvement of the quality of life for those patients afflicted by retinal degenerative diseases.
|
|
|
|
|
|
|
|
|
|
LambdaVision
|
|
Pharmaceuticals & Biotechnology
|
private:lambdavision-2
|
6930248
|
Feb 9th, 2018 12:00AM
|
LambdaVision, Inc.
|
46
|
6.00
|
Open
|
Biotechnology
|
Feb 9th, 2017 08:57AM
|
Feb 9th, 2017 08:57AM
|
LambdaVision, Inc. seeks to harness the photochemical properties of retinylidene proteins to develop a high-resolution, protein-based retinal prosthesis for the restoration of vision and improvement of the quality of life for those patients afflicted by retinal degenerative diseases.
|
|
|
|
|
|
|
|
|
|
LambdaVision
|
|
Pharmaceuticals & Biotechnology
|